{"id":"W4307852697","doi":"10.1007/s12325-022-02322-y","title":"No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab","year":2022,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Eli Lilly and Company; Ortho Dermatologics; Galderma; Incyte; Dermira; Les Laboratories Pierre Fabre; UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Medicine; Dupilumab; Atopic dermatitis; Discontinuation; Incidence (geometry); Placebo; Dosing; Internal medicine; Adverse effect; Regimen; Cumulative incidence; Dermatology; Cohort","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006279696,0.0001117783,0.0002732982,0.0001722674,0.00004704433,0.000003564139,0.00005653091,0.0000300929,0.00009895243],"category_scores_gemma":[0.00003216969,0.00009137067,0.00002935232,0.0002915772,0.00002924907,0.0001271029,0.0000126625,0.0001085491,0.000002862251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000678705,"about_ca_system_score_gemma":0.00006318521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007245932,"about_ca_topic_score_gemma":0.001115091,"domain_scores_codex":[0.9992344,0.00008780221,0.0001796421,0.0002010155,0.0001346232,0.0001625509],"domain_scores_gemma":[0.9995593,0.0000847338,0.00007341681,0.0001653792,0.00005702279,0.00006018653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01770032,0.0002605768,0.9667915,0.00007666475,0.0000514506,0.00005548984,0.0009826252,0.007357677,0.00002059636,0.00003571885,0.0002889828,0.006378474],"study_design_scores_gemma":[0.01769178,0.002017766,0.970772,0.0002580929,0.00002304306,0.00005878873,0.0001234167,0.0006891191,0.0006798871,0.0003246969,0.007179757,0.0001816773],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997555,0.0007137785,0.0001664405,0.00007551594,0.00005418212,0.0009880583,0.00005343445,0.00002611854,0.0003675104],"genre_scores_gemma":[0.9970526,0.000839617,0.0005676965,0.0008069379,0.00001264231,0.0005413736,0.00005003328,0.00001761588,0.0001115141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006890774,"threshold_uncertainty_score":0.3725988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005435478724070912,"score_gpt":0.2544706578341253,"score_spread":0.2490351791100543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}